skip to search skip to navigation skip to main content

Urology

As a global leader in urology, we have a rich portfolio of new medicines, considered by some to be among the strongest in the industry.

Urology makes up a significant proportion of primary care consultations.1 The most common conditions include those that affect bladder and prostate functions.

Astellas has a proven track record in urology. We offer a choice of treatment options for patients with overactive bladder syndrome (OAB), which affects around 17% of people in Europe and can cause urinary incontinence in over a third of patients.2 We also have a range of treatments for lower urinary tract symptoms (LUTs) associated with benign prostatic hyperplasia (BPH). LUTs can occur in up to 30% of men over the age of 65 years, and the symptoms they deal with can have a significant impact on their quality of life, one of the most frequent being nocturia (urinary frequency at night).3

 

bird_urology yellow

1. Arya M, Shergill IS, Silhi N, Grange P, Bott SRJ. Essential Urology in General Practice. Published by Quay Books, MA Healthcare Ltd. Available at http://www.quaybooks.co.uk/content/site121/filessamples/679978185642374_00000000326.pdf. Last accessed 12 February 2013.
2. Milsom I, et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001;87(9)760-6.
3. Rosette de la, J, et al. Guidelines on Benign Prostatic Hyperplasia. Available at http://www.uroweb.org/fileadmin/user_upload/Guidelines/11%20BPH.pdf Last accessed 11 Setpember 2014

Learn more about our therapy areas:

Privacy Policy  |  Terms of Use Copyright © 2018 Astellas Pharma